Genetically Modified T-cell Infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Modified T-cell Infusion, covering 2025-10-06 to 2025-10-06. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma [Phase 1]